Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU): The Phase 2 SATURN Study

Heissigerova J., Callanan D., de Smet M. D., Srivastava S. K., Karkanova M., Garcia-Garcia O., ...More

OPHTHALMOLOGY, vol.126, no.3, pp.428-437, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 126 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.1016/j.ophtha.2018.09.044
  • Journal Name: OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.428-437
  • Hacettepe University Affiliated: Yes


Purpose: To assess efficacy and safety of sarilumab, a human anti-interleukin-6 receptor antibody, for treatment of posterior segment noninfectious uveitis (NIU).